Delivery Order SPE2DB24D2205-SPE2DB25FEATX
Award Date
4/10/25
Potential Completion Date
4/11/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,430.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Adderall 5 mg tablets, a prescription medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...
This federal contract award, valued at $15,481.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADDERALL 10 MG TABLET 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award, valued at $3,540.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Adderall 20 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,141.71 delivery order contract is for the supply of Adderall 30 mg tablets, a prescription medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed-price pricing type and a final completion date of December 14, 2023. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Medical Supply Chain division of the Department of Defense's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $3,355.74 firm fixed-price delivery order is for the supply of 4,564,713,048 tablets of 5 mg Adderall, a prescription stimulant medication used to treat ADHD. The contract, which runs through May 2024, is not set aside for any special designation and was awarded on a full and open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,141.63 contract is for the delivery of Adderall 10 mg tablets to support federal healthcare programs. The contract is a firm-fixed price delivery order with a completion date of May 9, 2023. While the original solicitation details are not provided, the contract appears to be part of a larger Indefinite Delivery...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $6,263.86. It was issued by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) with the company that has a ceiling value of $999,999,999 and runs through November 2026. The delivery order is for 4,559,657,489 units of Adderall 10 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). This contract does not have any...
This federal contract award, valued at $9,318.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,566,831,561 tablets of Adderall 20 mg, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The award has an ultimate completion date of January 3, 2025 and utilizes a firm fixed-price pricing structure. This contract does...
This federal contract award, valued at $4,050.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Adderall 15 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The contract is a firm-fixed-price delivery order with a completion date of December 23, 2024. Amerisourcebergen holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,157.24 firm fixed-price delivery order is for the supply of Adderall 15 mg tablets, a medication used to treat ADHD and narcolepsy. The contract has an ultimate completion date of November 21, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...